Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Ruud Houben"'
Publikováno v:
Breast, Vol 78, Iss , Pp 103812- (2024)
Objectives: To systematically review risk factors for patient-reported arm symptoms (AS) in breast cancer (BC), considering radiotherapy (RT) impact, using the EORTC QLQ-BR23 questionnaire (BR23). Methods: PubMed, Embase, Cochrane Library, MEDLINE, a
Externí odkaz:
https://doaj.org/article/8f036b9da5b544f19230370b1f38ce2e
Autor:
Haiyan Zeng, Danyang Zheng, Willem J. A. Witlox, Antonin Levy, Alberto Traverso, Feng-Ming (Spring) Kong, Ruud Houben, Dirk K. M. De Ruysscher, Lizza E. L. Hendriks
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
The use of prophylactic cranial irradiation (PCI) for small cell lung cancer (SCLC) patients is controversial. Risk factors for brain metastasis (BM) development are largely lacking, hampering personalized treatment strategies. This study aimed to id
Externí odkaz:
https://doaj.org/article/c55bdab3374f4d1da01c0ea78010340a
Autor:
Linda Spiegelberg, Ruud Houben, Raymon Niemans, Dirk de Ruysscher, Ala Yaromina, Jan Theys, Christopher P. Guise, Jeffrey B. Smaill, Adam V. Patterson, Philippe Lambin, Ludwig J. Dubois
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 15, Iss , Pp 62-69 (2019)
Hypoxia-activated prodrugs (HAPs) are designed to specifically target the hypoxic cells of tumors, which are an important cause of treatment resistance to conventional therapies. Despite promising preclinical and clinical phase I and II results, the
Externí odkaz:
https://doaj.org/article/75c6748e20a543519df6ae43fdf0f2f0
Autor:
Juliette Degens, D De Ruysscher, Ruud Houben, Bastiaan Kietselaer, Gerben Bootsma, Lizza Hendriks, Ellen Huijbers, Annemie Schols, Anne-Marie C Dingemans
Publikováno v:
BMJ Open, Vol 10, Iss 9 (2020)
Objectives Dyspnoea is one of the symptoms frequently encountered after treatment with chemoradiotherapy (CRT) in stage III non-small cell lung cancer (NSCLC). Long-term data on mild to moderately severe cardiac events as underlying cause of dyspnoea
Externí odkaz:
https://doaj.org/article/10315a0b5ae54b35bed36de7c048a376
Autor:
Venus Sosa Iglesias, Jan Theys, Arjan J. Groot, Lydie M. O. Barbeau, Alyssa Lemmens, Ala Yaromina, Mario Losen, Ruud Houben, Ludwig Dubois, Marc Vooijs
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Background: Lung cancer is the leading cause of cancer death worldwide. More effective treatments are needed to increase durable responses and prolong patient survival. Standard of care treatment for patients with non-operable stage III-IV NSCLC is c
Externí odkaz:
https://doaj.org/article/0220edbc70dd4d41a14051264307e964
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Hypoxia-inducible factor-2α (HIF-2α) plays an important role in tumor progression and metastasis. A number of studies have evaluated the correlation between HIF-2α overexpression and clinical outcome in cancer patients but yielded inconsistent res
Externí odkaz:
https://doaj.org/article/c85e4c4e698c4b8f81e6cb06c8e63384
Autor:
Haiyan Zeng, Lizza E.L. Hendriks, Willem J.A. Witlox, Harry J.M. Groen, Anne-Marie C. Dingemans, John Praag, José Belderbos, Ruud Houben, Vincent van der Noort, Dirk K.M. De Ruysscher
Publikováno v:
Radiotherapy and Oncology, 183:109627. Elsevier Ireland Ltd
Radiotherapy and Oncology, 183:109627. ELSEVIER IRELAND LTD
Radiotherapy and Oncology, 183:109627. ELSEVIER IRELAND LTD
Aim: To identify risk factors for self-reported cognitive impairment in radically treated stage III non-small cell lung cancer (NSCLC). Methods: Cognitive functioning was assessed using the EORTC-QLQ-C30 at seven pre-specified time points in the phas
Autor:
J. Verloop, Adri C. Voogd, Paula H.M. Elkhuizen, Philip Poortmans, Liesbeth J. Boersma, A. Elise van Leeuwen, Ruud Houben, Sabine C. Linn, Ruud M. Pijnappel, Jelle Wesseling, Thijs van Dalen, Luc J. A. Strobbe, Linda de Munck
Publikováno v:
Radiotherapy and Oncology, 145, 201-208. Elsevier Ireland Ltd
Background We conducted a prospective cohort study in the Netherlands (RAPCHEM: NCT01279304, BOOG 2010-03) in breast cancer (BC) patients treated with primary systemic therapy (PST), followed by surgery and post-operative radiation therapy (RT) accor
Autor:
Ruud Houben, Jarno Melenhorst, Murillo Bellezzo, Heike I. Grabsch, Rodrigo Oliva Perez, Frank Verhaegen, Nathalie Guedj, Angelita Habr-Gama, Danny Goudkade, Krzysztof Bujko, Evert J. Van Limbergen, Maaike Berbee, Ben G. L. Vanneste, Gabriel P. Fonseca, Jeroen Buijsen, An-Sofie Verrijssen, Jose G. Guillem
Publikováno v:
Radiother Oncol
Objective: In selected rectal cancer patients with residual local disease following neoadjuvant chemoradiation (CRT) and the preference of an organ preservation pathway, additional treatment with dose escalation by endoluminal radiotherapy (RT) may u
Autor:
Antonio Angrisani, Ruud Houben, Florit Marcuse, Monique Hochstenbag, Jos Maessen, Dirk De Ruysscher, Stephanie Peeters
Publikováno v:
Mediastinum. 6:AB004-AB004